MEDIROM HEALTHCARE TECHNOLOG (MRM) Stock Fundamental Analysis
USA - NASDAQ:MRM - US58510H1032 - ADR
2 USD
-0.07 (-3.38%)
MRM gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 79 industry peers in the Diversified Consumer Services industry. Both the profitability and financial health of MRM have multiple concerns. MRM has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year MRM has reported negative net income.
MRM had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: MRM reported negative net income in multiple years.
In the past 5 years MRM always reported negative operating cash flow.
1.2 Ratios
MRM has a Return On Assets (1.84%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 15.94%, MRM is in the better half of the industry, outperforming 75.95% of the companies in the same industry.
MRM has a Return On Invested Capital (0.09%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 15.94% | ||
| ROIC | 0.09% |
ROA(3y)1.91%
ROA(5y)-4.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 1.79%, MRM is in line with its industry, outperforming 53.16% of the companies in the same industry.
MRM's Profit Margin has improved in the last couple of years.
MRM has a Operating Margin (0.06%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of MRM has declined.
MRM's Gross Margin of 27.07% is on the low side compared to the rest of the industry. MRM is outperformed by 69.62% of its industry peers.
MRM's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.06% | ||
| PM (TTM) | 1.79% | ||
| GM | 27.07% |
OM growth 3YN/A
OM growth 5Y-50.92%
PM growth 3YN/A
PM growth 5Y32.28%
GM growth 3Y1.14%
GM growth 5Y2.16%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MRM is destroying value.
The number of shares outstanding for MRM has been increased compared to 1 year ago.
MRM has more shares outstanding than it did 5 years ago.
MRM has a worse debt/assets ratio than last year.
2.2 Solvency
MRM has an Altman-Z score of 1.06. This is a bad value and indicates that MRM is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.06, MRM is in line with its industry, outperforming 55.70% of the companies in the same industry.
A Debt/Equity ratio of 1.35 is on the high side and indicates that MRM has dependencies on debt financing.
MRM's Debt to Equity ratio of 1.35 is on the low side compared to the rest of the industry. MRM is outperformed by 67.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.06 |
ROIC/WACC0.04
WACC2.29%
2.3 Liquidity
A Current Ratio of 0.65 indicates that MRM may have some problems paying its short term obligations.
MRM has a worse Current ratio (0.65) than 77.22% of its industry peers.
A Quick Ratio of 0.61 indicates that MRM may have some problems paying its short term obligations.
MRM's Quick ratio of 0.61 is on the low side compared to the rest of the industry. MRM is outperformed by 77.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.65 | ||
| Quick Ratio | 0.61 |
3. Growth
3.1 Past
The earnings per share for MRM have decreased strongly by -180.69% in the last year.
The Earnings Per Share has been growing by 47.92% on average over the past years. This is a very strong growth
The Revenue has grown by 21.55% in the past year. This is a very strong growth!
Measured over the past years, MRM shows a quite strong growth in Revenue. The Revenue has been growing by 16.25% on average per year.
EPS 1Y (TTM)-180.69%
EPS 3YN/A
EPS 5Y47.92%
EPS Q2Q%24.67%
Revenue 1Y (TTM)21.55%
Revenue growth 3Y15.33%
Revenue growth 5Y16.25%
Sales Q2Q%34.55%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for MRM. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MRM is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 13.36 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
MRM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:MRM (11/20/2025, 1:46:29 PM)
2
-0.07 (-3.38%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners1.43%
Inst Owner Change126.05%
Ins Owners25.57%
Ins Owner ChangeN/A
Market Cap15.80M
Revenue(TTM)8.30B
Net Income(TTM)148.76M
Analysts0
Price TargetN/A
Short Float %8.2%
Short Ratio0.16
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.3 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.64 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.36 |
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.54
FCFYN/A
OCF(TTM)-1.08
OCFYN/A
SpS6.73
BVpS0.76
TBVpS-0.48
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 15.94% | ||
| ROCE | 0.12% | ||
| ROIC | 0.09% | ||
| ROICexc | 0.09% | ||
| ROICexgc | 0.13% | ||
| OM | 0.06% | ||
| PM (TTM) | 1.79% | ||
| GM | 27.07% | ||
| FCFM | N/A |
ROA(3y)1.91%
ROA(5y)-4.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-46.9%
ROICexc growth 3YN/A
ROICexc growth 5Y-50.51%
OM growth 3YN/A
OM growth 5Y-50.92%
PM growth 3YN/A
PM growth 5Y32.28%
GM growth 3Y1.14%
GM growth 5Y2.16%
F-Score6
Asset Turnover1.03
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.26 | ||
| Cap/Depr | 194.74% | ||
| Cap/Sales | 6.81% | ||
| Interest Coverage | 0.1 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.65 | ||
| Quick Ratio | 0.61 | ||
| Altman-Z | 1.06 |
F-Score6
WACC2.29%
ROIC/WACC0.04
Cap/Depr(3y)216.74%
Cap/Depr(5y)157.89%
Cap/Sales(3y)7.57%
Cap/Sales(5y)5.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-180.69%
EPS 3YN/A
EPS 5Y47.92%
EPS Q2Q%24.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21.55%
Revenue growth 3Y15.33%
Revenue growth 5Y16.25%
Sales Q2Q%34.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y101.04%
EBIT growth 3YN/A
EBIT growth 5Y-42.95%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-110.8%
OCF growth 3YN/A
OCF growth 5YN/A
MEDIROM HEALTHCARE TECHNOLOG / MRM FAQ
What is the ChartMill fundamental rating of MEDIROM HEALTHCARE TECHNOLOG (MRM) stock?
ChartMill assigns a fundamental rating of 2 / 10 to MRM.
Can you provide the valuation status for MEDIROM HEALTHCARE TECHNOLOG?
ChartMill assigns a valuation rating of 0 / 10 to MEDIROM HEALTHCARE TECHNOLOG (MRM). This can be considered as Overvalued.
Can you provide the profitability details for MEDIROM HEALTHCARE TECHNOLOG?
MEDIROM HEALTHCARE TECHNOLOG (MRM) has a profitability rating of 3 / 10.
Can you provide the financial health for MRM stock?
The financial health rating of MEDIROM HEALTHCARE TECHNOLOG (MRM) is 0 / 10.